SM
KITE

Sabby Management’s Kite Pharma, Inc. KITE Stock Holding History

Sabby Management’s Portfolio KITE Stock Details KITE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		– Sell
-543
Closed -$9.76M – 221
2017
Q3 		$9.76M Sell
543
-248
-31% -$34.6K 0.64% 21
2017
Q2 		$8.2M Buy
791
+500
+172% +$40.8K 0.54% 28
2017
Q1 		$2.28M Hold
291
– – 0.12% 81
2016
Q4 		$1.3M Sell
291
-886
-75% -$43.5K 0.08% 133
2016
Q3 		$6.58M Buy
+1,177
New +$65.6K 0.25% 62
2016
Q1 		– Sell
-808
Closed -$4.98M – 386
2015
Q4 		$4.98M Sell
808
-1,015
-56% -$71.4K 0.27% 62
2015
Q3 		$10.2M Buy
1,823
+1,721
+1,687% +$108K 0.42% 42
2015
Q2 		$622K Buy
102
+4
+4% +$228 0.02% 248
2015
Q1 		$565K Buy
+98
New +$6.57K 0.02% 227

Sabby Management's KITE Position: Q3 2017 in Review

Sabby Management sold out of Kite Pharma, Inc. (KITE) in Q3 2017, closing a stake of 31,384 shares — an estimated $4.37M sold.

Sabby Management first reported a position in KITE in Q2 2015 and held it in 4 quarters. The position peaked at $7.63M in Q3 2015. 244 funds tracked by Wall St. Rank hold KITE as of Q3 2017.

  • Sabby Management reported no remaining Kite Pharma, Inc. position as of Q3 2017 after selling out during the quarter.
  • Sabby Management sold 31,384 Kite Pharma, Inc. shares in Q3 2017, an estimated $4.37M.
  • Sabby Management first reported a position in Kite Pharma, Inc. in Q2 2015 and held it in 4 quarters.
  • Sabby Management's Kite Pharma, Inc. position peaked at $7.63M in Q3 2015.
  • 244 funds tracked by Wall St. Rank held Kite Pharma, Inc. as of Q3 2017.

Based on Sabby Management's 13F filing for Q3 2017, filed 14 Nov 2017.